Depression, illness severity, and healthcare utilization in cystic fibrosis

Pediatric Pulmonology

Volumn 49, Issue 12, 2014, Pages 1177-1181

  Snell, Carolyn ^a   Fernandes, Serena ^a   Bujoreanu, I Simona ^a   Garcia, Georgina ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adherence; Children; Cystic fibrosis; Depression; Healthcare cost

Indexed keywords

ADJUSTMENT DISORDER; ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; DYSTHYMIA; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; JUVENILE; LUNG FIBROSIS; MAJOR DEPRESSION; MALE; MEDICATION COMPLIANCE; MOOD DISORDER; REVIEW; SCHOOL CHILD; TREATMENT OUTCOME; YOUNG ADULT; BODY MASS; CYSTIC FIBROSIS; DEPRESSIVE DISORDER; ECONOMICS; HOSPITALIZATION; OUTPATIENT DEPARTMENT; PSYCHOLOGY; REGISTER; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION;

ADOLESCENT; AMBULATORY CARE FACILITIES; BODY MASS INDEX; CYSTIC FIBROSIS; DEPRESSIVE DISORDER; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; MALE; MATCHED-PAIR ANALYSIS; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84911960068     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22990     Document Type: Review

References (24)

1. Ouyang L, Grosse SD, Amendah DD, Schechter MS. Healthcare expenditures for privately insured people with cystic fibrosis. Pediatr Pulmonol 2009;4:989-996.
2. Cystic Fibrosis Foundation. Patient Registry. Bethesda, MD: Cystic Fibrosis Foundation. 2008-2012.
3. Briesacher BA, Quittner AL, Fouayzi H, Zhang J, Swensen A. Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF). Pediatr Pulmonol 2011;46:770-776.
4. Di Matteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-2107.
5. Quittner AL, Barker DH, Snell C, Grimley ME, Marciel KK, Cruz I. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008;14:582-588.
6. DiGirolamo AM, Quittner AL, Ackerman V, Stevens J. Identification and assessment of ongoing stressors in adolescents with a chronic illness: an application of the behavior-analytic model. J Clin Child Psychol 1997;26:53-66.
7. Smith BA, Modi AC, Quittner AL, Wood BL. Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulm 2010;45:756-763.
8. Besier T, Quittner AL, Goldbeck L. Symptoms of anxiety and depression, pulmonary function and their association with life satisfaction in patients with cystic fibrosis. J Cyst Fibros 2008;7:S107.
9. Havermans T, Colpaert K, Dupont LJ. Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros 2008;7:581-584.
10. Riekert KA, Bartlett SJ, Boyle MP, Krishnan JA, Rand CS. The association between depression, lung function and health-related quality of life among adults with cystic fibrosis. Chest 2007;132:231-237.
11. Konstan MW, Schluchter MD, Xue W, Davis PB. Clinical use of ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis. Am J Respir Crit Care Med 2007;176:1084-1089.
12. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve: normal standards, variability, and effects of age. Am Rev Respir Dis 1976;113:587-600.
13. Zemel BS, Jawad AF, Fitz Simmons S, Stallings VA. Longitudinal relationship among growth nutritional status and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. Pediatrics 2000;137:374-380.
14. Georgiopoulos AM, Hua LL. The diagnosis and treatment of attention deficit-hyperactivity disorder in children and adolescents with cystic fibrosis: a retrospective study. Psychosomatics 2011;52:160-166.
15. Richardson LP, Russo JE, Lozano P, McCauley E, Katon W. The effect of comorbid anxiety and depressive disorders on health care utilization and costs among adolescents with asthma. Gen Hosp Psychiatry 2008;30:398-406.
16. Hendrie HC, Lindgren D, Hay DP, Lane KA, Gao S, Purnell C, Munger S, Smith F, Dickens J, Boustani MA, Callahan CM. Comobidity profile and healthcare utilization in elderly patients with serious mental illnesses. Am J Geriatr Psychiatry 2013;21:1267-1276.
17. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278-3285.
18. Cramer JA, Blum D, Fanning K, Reed M. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004;5:337-342.
19. Heimeshoff M, Hollmeyer H, Schreyogg J, Tiemann O, Stabb D. Cost of illness of cystic fibrosis in Germany. Pharmacoeconomics 2012;30:763-777.
20. Bradley JM, Blume SW, Balp M, Honeybourne D, Elborn JS. Quality of life and healthcare utilization in cystic fibrosis: a multicenter study. Eur Respir J 2013;41:571-577.
21. Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP. National institute of mental health treatment of depression collaborative research program. General effectiveness of treatments. Arch Gen Psychiatry 1989;46:971-982.
22. Szigethy E, Noll RB. Individual psychotherapy. In: Shaw RJ, DeMaso DR, editors. Textbook of pediatric psychosomatic medicine. Washington: American Psychiatric Publishing; 2010. p 423-438.
23. Katon W, Lin E H B, Von Korff M, Ciechanowski P, Ludman E, Young B, Rutter C, Oliver M, MacGregor M. Integrating depression and chronic disease care among patients with diabetes and/or coronary artery disease: the design of the TEAMcare study. Contemporary Clinical Trials 2010;31:312-322.
24. Jortberg BT, Miller BF, Gabbay RA, Sparling K, Dickinson WP. Patient-centered medical home: how it affects psychosocial outcomes for diabetes. Curr Diab Rep 2012;12:721-728.